We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$1.67B
Turnover
44.44%
1-Year Est. Return
1.43%
This Fund
S&P 500
This Quarter
Est. Return
+1.91%
1 Year Est. Return
-1.43%
3 Year Est. Return
-6.61%
5 Year Est. Return
-27.23%
10 Year Est. Return
–
AUM
$1.67B
AUM Growth
-$505M
(-23%)
Cap. Flow
-$520M
Cap. Flow
% of AUM
-31.03%
Top 10 Holdings %
Top 10 Hldgs %
29.21%
Holding
171
New
21
Increased
23
Reduced
68
Closed
55
Avg Time Held Equity + Options
1.1
years
Top 10 Avg Time Held Equity + Options
0.6
years
Top 20 Avg Time Held Equity + Options
0.8
years
Avg Time Held Equity only
1.1
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$47.1M |
| 2 |
Becton Dickinson
BDX
|
+$40.9M |
| 3 |
Universal Health Services
UHS
|
+$39.4M |
| 4 |
Intuit
INTU
|
+$37.1M |
| 5 |
SPS Commerce
SPSC
|
+$33.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chord Energy
CHRD
|
+$73.2M |
| 2 |
Teleflex
TFX
|
+$52.2M |
| 3 |
Akamai
AKAM
|
+$46.6M |
| 4 |
RingCentral
RNG
|
+$30.2M |
| 5 |
Haemonetics
HAE
|
+$28.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.19% |
| 2 | Healthcare | 19.57% |
| 3 | Industrials | 14.44% |
| 4 | Consumer Discretionary | 10.33% |
| 5 | Communication Services | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
QuantumScape Corp
QS
$2.43B
| $2.22M | 0.13% |
293,708
-68,647
| -19% | -$515K |
2026 Q1
1 quarter
|
|
102
Central Garden & Pet Co Class A
CENTA
$2.23B
| $2.16M | 0.13% |
55,760
-395,568
| -88% | -$13.8M |
2025 Q4
2 quarters
|
|
103
Hurco Companies Inc
HURC
$134M
| $2.08M | 0.12% |
90,967
-25,761
| -22% | -$465K |
2021 Q2
20 quarters
|
|
104
Resources Connection
RGP
$94.7M
| $2.03M | 0.12% |
476,710
-131,105
| -22% | -$551K |
2024 Q1
9 quarters
|
|
105
DELISTED
GETTY IMAGES HLDGS INC A
GETY
| $1.99M | 0.12% |
2,316,030
-745,164
| -24% | -$645K |
2025 Q1
5 quarters
|
|
106
Fox Factory Holding Corp
FOXF
$735M
| $1.93M | 0.12% |
+114,060
| New | +$1.99M |
2026 Q2
0 quarters
|
|
107
Maximus
MMS
$3.02B
| $1.83M | 0.11% |
+34,026
| New | +$2.12M |
2026 Q2
0 quarters
|
|
108
8x8 Inc
EGHT
$290M
| $1.4M | 0.08% |
818,755
-1,102,420
| -57% | -$2.22M |
2023 Q2
12 quarters
|
|
109
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.3B
| $561K | 0.03% |
797
| – | – |
2025 Q2
4 quarters
|
|
110
Endava
DAVA
$101M
| $408K | 0.02% |
144,240
-566,105
| -80% | -$2.09M |
2025 Q4
2 quarters
|
|
111
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$49B
| $302K | 0.02% |
3,500
| – | – |
2025 Q4
2 quarters
|
|
112
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.34B
| $271K | 0.02% |
7,388
| – | – |
2025 Q2
4 quarters
|
|
113
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.62B
| $244K | 0.01% |
4,822
| – | – |
2025 Q3
3 quarters
|
|
114
Lexaria Bioscience
LEXX
$5.94M
| $194K | 0.01% |
23,046
-6,441
| -22% | -$69.8K |
2021 Q1
21 quarters
|
|
115
American Vanguard Corp
AVD
$33.3M
| $177K | 0.01% |
63,349
-353,491
| -85% | -$960K |
2023 Q3
11 quarters
|
|
116
UNIFI
UFI
$106M
| $120K | 0.01% |
25,252
-375,595
| -94% | -$1.49M |
2022 Q3
15 quarters
|
|
117
Acadia Healthcare
ACHC
$2.95B
| – | – |
-1,182,331
| Closed | -$27.7M | – |
|
|
118
Akamai
AKAM
$13.2B
| – | – |
-405,632
| Closed | -$46.6M | – |
|
119
Alight
ALIT
$238M
| – | – |
-101,143
| Closed | -$1.18M | – |
|
120
Dauch Corp
DCH
$1.23B
| – | – |
-556,876
| Closed | -$3.3M | – |
|
121
Belden
BDC
$4.07B
| – | – |
-28,440
| Closed | -$3.27M | – |
|
122
BlackLine
BL
$1.7B
| – | – |
-235,012
| Closed | -$8.7M | – |
|
123
Maplebear
CART
$11.7B
| – | – |
-255,043
| Closed | -$9.55M | – |
|
|
124
Chord Energy
CHRD
$8B
| – | – |
-515,084
| Closed | -$73.2M | – |
|
125
ConocoPhillips
COP
$171B
| – | – |
-146,220
| Closed | -$19.3M | – |
|
Similar funds
IAIM
ACM
CC
CUAMC
SH
ZBNA
DG
KRSITF
Invenomic Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Invenomic Capital Management held 171 positions worth $1.67B, down 23% from $2.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invenomic Capital Management withdrew a net $520M in Q2 2026, closing 55 positions and reducing 68 holdings. Its most notable exit was Chord Energy, an estimated $73.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Invenomic Capital Management opened a new position in Charter Communications worth $40.2M.
- Invenomic Capital Management's largest Q2 2026 buy was Charter Communications: 282,416 shares worth $40.2M.
- Invenomic Capital Management added most to Universal Health Services in Q2 2026, an estimated $39.4M increase.
- Invenomic Capital Management's biggest Q2 2026 reduction was Haemonetics, cutting an estimated $28.8M.
- Invenomic Capital Management fully exited Chord Energy in Q2 2026, selling an estimated $73.2M.
- Invenomic Capital Management's ten largest holdings make up 29% of its $1.67B portfolio in Q2 2026.
- Invenomic Capital Management opened 21 new positions and closed 55 in Q2 2026.
- Invenomic Capital Management's portfolio value fell 23% quarter-over-quarter to $1.67B.
Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.